Search Results - "Krendelchtchikov, Alexandre"

Tetraspanin blockage reduces exosome-mediated HIV-1 entry by Sims, Brian, Farrow, Anitra L., Williams, Sparkle D., Bansal, Anju, Krendelchtchikov, Alexandre, Matthews, Qiana L.

“…HIV-1 is one of the most studied retroviruses. The role of exosomes in HIV-1 entry and pathogenesis are beginning to be appreciated. Exosomes can incorporate…”
Get full text

A Novel Vaccine Approach for Chagas Disease Using Rare Adenovirus Serotype 48 Vectors by Farrow, Anitra L, Peng, Binghao J, Gu, Linlin, Krendelchtchikov, Alexandre, Matthews, Qiana L

“…Due to the increasing amount of people afflicted worldwide with Chagas disease and an increasing prevalence in the United States, there is a greater need to…”
Get full text

Using multivalent adenoviral vectors for HIV vaccination by Gu, Linlin, Li, Zan C, Krendelchtchikov, Alexandre, Krendelchtchikova, Valentina, Wu, Hongju, Matthews, Qiana L

“…Adenoviral vectors have been used for a variety of vaccine applications including cancer and infectious diseases. Traditionally, Ad-based vaccines are designed…”
Get full text

Alcohol Exposure Impacts the Composition of HeLa-Derived Extracellular Vesicles by Jones, Leandra B, Kumar, Sanjay, Curry, Aliyah J, Price, Jayde S, Krendelchtchikov, Alexandre, Crenshaw, Brennetta J, Bell, Courtnee' R, Williams, Sparkle D, Tolliver, Tambre A, Saldanha, Sabita N, Sims, Brian, Matthews, Qiana L

“…Extracellular vesicles are nanosized vesicles that are under intense investigation for their role in intercellular communication. Extracellular vesicles have…”
Get full text

Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors by Borovjagin, Anton V, Krendelchtchikov, Alexandre, Ramesh, Nagarajan, Yu, De-Chao, Douglas, Joanne T, Curiel, David T

“…The use of adenovirus type 5 (Ad5) for cancer therapy is limited by deficiency of its primary cell attachment receptor, coxsackie and adenovirus receptor…”
Get full text

Epitope Capsid-Incorporation: New Effective Approach for Vaccine Development for Chagas Disease by Matthews, Qiana L, Farrow, Anitra L, Rachakonda, Girish, Gu, Linlin, Nde, Pius, Krendelchtchikov, Alexandre, Pratap, Siddharth, Sakhare, Shruti S, Sabbaj, Steffanie, Lima, Maria F, Villalta, Fernando

“…Previously we reported that a hexon-modified adenovirus (Ad) vector containing the invasive neutralizing epitope of ( trypomastigote gp83 (Ad5-gp83) provided…”
Get full text

Differential binding of the HIV-1 envelope to phosphatidylserine receptors by Gu, Linlin, Sims, Brian, Krendelchtchikov, Alexandre, Tabengwa, Edlue, Matthews, Qiana L.

“…Prior work has shown that the HIV-1 envelope of the human immunodeficiency virus (HIV) interacts directly with T-cell immunoglobulin mucin (TIM) family…”
Get full text

Role of TIM-4 in exosome-dependent entry of HIV-1 into human immune cells by Sims, Brian, Farrow, Anitra L, Williams, Sparkle D, Bansal, Anju, Krendelchtchikov, Alexandre, Gu, Linlin, Matthews, Qiana L

“…Exosomes, 30-200 nm nanostructures secreted from donor cells and internalized by recipient cells, can play an important role in the cellular entry of some…”
Get full text

Neural stem cell-derived exosomes mediate viral entry by Sims, Brian, Gu, Linlin, Krendelchtchikov, Alexandre, Matthews, Qiana L

“…Viruses enter host cells through interactions of viral ligands with cellular receptors. Viruses can also enter cells in a receptor-independent fashion…”
Get full text

Adenoviral vectors elicit humoral immunity against variable loop 2 of clade C HIV-1 gp120 via “Antigen Capsid-Incorporation” strategy by Gu, Linlin, Krendelchtchikova, Valentina, Krendelchtchikov, Alexandre, Farrow, Anitra L, Derdeyn, Cynthia A, Matthews, Qiana L

“…Abstract Adenoviral (Ad) vectors in combination with the "Antigen Capsid-Incorporation" strategy have been applied in developing HIV-1 vaccines, due to the…”
Get full text

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches by Gu, Linlin, Farrow, Anitra L., Krendelchtchikov, Alexandre, Matthews, Qiana L.

Get full text

Utilizing the antigen capsid-incorporation strategy for the development of adenovirus serotype 5-vectored vaccine approaches by Gu, Linlin, Farrow, Anitra L, Krendelchtchikov, Alexandre, Matthews, Qiana L

“…Adenovirus serotype 5 (Ad5) has been extensively modified with traditional transgene methods for the vaccine development. The reduced efficacies of these…”
Get full text

A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the "Antigen Capsid-Incorporation" strategy by Gu, Linlin, Krendelchtchikova, Valentina, Krendelchtchikov, Alexandre, Oster, Robert A, Fujihashi, Kohtaro, Matthews, Qiana L

“…Due to potential advantages, human adenoviral vectors have been evaluated pre-clinically as recombinant vaccine vectors against several cancers and infectious…”
Get full text

Development of an Ad5H3 Chimera Using the "Antigen Capsid-Incorporation" Strategy for an Alternative Vaccination Approach by Gu, Linlin, Icyuz, Mert, Krendelchtchikova, Valentina, Krendelchtchikov, Alexandre, Johnston, Alison E, Matthews, Qiana L

“…Adenovirus type 5 (Ad5) achieved success as a conventional transgene vaccine vector in preclinical trials, however; achieved poor efficiency in some of the…”
Get full text

Using Multivalent Adenoviral Vectors for HIV Vaccination. e60347 by Gu, Linlin, Li, Zan C, Krendelchtchikov, Alexandre, Krendelchtchikova, Valentina, Wu, Hongju, Matthews, Qiana L

“…Adenoviral vectors have been used for a variety of vaccine applications including cancer and infectious diseases. Traditionally, Ad-based vaccines are designed…”
Get full text